Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1 Current treatments for PNETs

Published byἸωσίας Δημητρακόπουλος Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1 Current treatments for PNETs"— Presentation transcript:

1 Figure 1 Current treatments for PNETs
Figure 1 | Current treatments for PNETs. Medical therapy includes drugs and antibodies that target different pathways in cancer cells. Surgery involves the removal or resection of the pancreatic neuroendocrine tumour (PNET). Radiological treatment involves particles or high-frequency waves being delivered externally or internally (for instance, intra-arterially) to the tumour. IFNAR, interferon α/β receptor; mTOR, mechanistic target of rapamycin; RTK, receptor tyrosine kinase; SSA, somatostatin analogue; SSTR, somatostatin receptor; VEGFA, vascular endothelial growth factor A; VEGFR, vascular endothelial growth factor receptor. Frost, M. et al. (2018) Current and emerging therapies for PNETs in patients with or without MEN1 Nat. Rev. Endocrinol. doi: /nrendo

Download ppt "Figure 1 Current treatments for PNETs"

Similar presentations

© 2005 Prentice Hall Inc. / A Pearson Education Company / Upper Saddle River, New Jersey 07458 Lung Cancer and Gefitinib  Lung cancer statistics in the.

© 2005 Prentice Hall Inc. / A Pearson Education Company / Upper Saddle River, New Jersey Lung Cancer and Gefitinib  Lung cancer statistics in the.
Samsung Genome Institute Samsung Medical Center

Samsung Genome Institute Samsung Medical Center
Silvestri Gerard A. , MD, FCCP, Rivera M. Patricia , MD, FCCP  CHEST 

Silvestri Gerard A. , MD, FCCP, Rivera M. Patricia , MD, FCCP  CHEST 
Anesthes. 2012;116(4): doi: /ALN.0b013e31824b9512 Figure Legend:

Anesthes. 2012;116(4): doi: /ALN.0b013e31824b9512 Figure Legend:
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Childhood craniopharyngioma

Figure 3 Childhood craniopharyngioma
Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.

Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.
Figure 2 Coronary vessels in atherosclerosis

Figure 2 Coronary vessels in atherosclerosis
Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trials  Pippa Newell, Augusto Villanueva, Josep M. Llovet 

Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trials  Pippa Newell, Augusto Villanueva, Josep M. Llovet 
Figure 1 Cellular processes involved in cancer development

Figure 1 Cellular processes involved in cancer development
Figure 5 Schematic illustration of different clinical trial designs

Figure 5 Schematic illustration of different clinical trial designs
Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors

Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors
Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era  Joon H. Uhm, MD, Alyx B. Porter,

Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era  Joon H. Uhm, MD, Alyx B. Porter,
Figure 3 Monitoring clonal evolution using liquid biopsies

Figure 3 Monitoring clonal evolution using liquid biopsies
Figure 1 Key time points in the discovery and development of imatinib for the treatment of chronic myeloid leukaemia (CML) and gastrointestinal stromal.

Figure 1 Key time points in the discovery and development of imatinib for the treatment of chronic myeloid leukaemia (CML) and gastrointestinal stromal.
Potential pathways directly linking obesity with cancer.

Potential pathways directly linking obesity with cancer.
Figure 5 MRI of childhood craniopharyngioma

Figure 5 MRI of childhood craniopharyngioma
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Similar presentations

Ads by Google